• Explore /
  • Poster
  • / Efficacy of niraparib maintenance therapy in Chinese women with platinum-sensitive recurrent ovarian cancer with and without secondary cytoreductive surgery: Results from the NORA trial.

Efficacy of niraparib maintenance therapy in Chinese women with platinum-sensitive recurrent ovarian cancer with and without secondary cytoreductive surgery: Results from the NORA trial.

Abstract Video & Slides Poster

Authors

null

Lingying Wu

National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Lingying Wu , Xiaohua Wu , Jianqing Zhu , Rutie Yin , Jiaxin Yang , Jihong Liu , Jing Wang , Ziling Liu , Yunong Gao , Danbo Wang , Ge Lou , Hongying Yang , Qi Zhou , Beihua Kong , Yi Huang , Lipai Chen , Guiling Li , Ruifang An , Tao Tan , Juan Dong

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Clinical Trial Registration Number

NCT03705156

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 5534)

DOI

10.1200/JCO.2021.39.15_suppl.5534

Abstract #

5534

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Beihua Kong

First Author: Jing Wang

Poster

2019 ASCO Annual Meeting

Recurrence of ovarian cancer in <em>BRCA</em>wt patients without maintenance therapy: Real-world evidence.

Recurrence of ovarian cancer in BRCAwt patients without maintenance therapy: Real-world evidence.

First Author: Melinda Louie-Gao

First Author: Michele Bartoletti